Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
United Therapeutics
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
United Therapeutics Announces FDA Approval and Launch of Tyvaso for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
United Therapeutics: Enabling Inspiration
PR-M04-21-003
Apr 02, 2021
3D Bioprinting
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
United Therapeutics Corporation
PR-M10-18-NI-095-3497
Oct 26, 2018
FDA Approval
United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
United Therapeutics Corporation
PR-M08-18-NI-016
Aug 06, 2018
